New combo attack on rare cancers before surgeons operate
NCT ID NCT03307616
Summary
This study is testing whether giving immune-boosting drugs, with or without radiation, before surgery can help shrink tumors and improve outcomes for patients with two specific types of rare soft tissue cancers. The goal is to see if this pre-surgery treatment makes the cancer easier to remove and reduces the chance of it coming back. Researchers will compare different drug combinations to find the most effective approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT DEDIFFERENTIATED LIPOSARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.